3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
41
Lung Neoplasms
13
Neoplasms
6
Neoplasm Metastasis
4
Thoracic Neoplasms
2
Noonan Syndrome
2
NSCLC
2
Meningeal Carcinomatosis
2
Colorectal Neoplasms
2
Carcinoma, Squamous Cell
2
Brain Neoplasms
2
Adenocarcinoma of Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
T790M Positive NSCLC Patients
1
Solid Tumor
1
Skin Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Renal Insufficiency
1
Progression Free Survival
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Non Small Cell Lung Cancer Metastatic
1
Neoplasms, Squamous Cell
1
Neoplasms by Site
1
Lung Diseases
1
Locally Advanced or Metastatic EGFR T790M+ NSCLC
1
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
1
Interventions
osimertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
EGF-R Positive Non-Small Cell Lung Cancer
×
osimertinib
×
Clear all
NCT04965701
2023-11-13
FLOWER
Istituto Oncologico Veneto IRCCS
Completed
200 enrolled